Free shipping over EUR 200Independent Third-Party COAssupport@certapeptides.comLive Chat
Retatrutide
GLP-1 and Incretin Research Peptides

Retatrutide

5mg· HPLC 99.163% In stock
€44.49

Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies. Triple hormone receptor agonism (GIP/GLP-1/Glucagon) Metabolic pathway modulation research Energy homeostasis and body composition studies For research purposes only.

Size
1
View cart
NameRetatrutide
Size5mg
SKUCP-RT5
HPLC Purity99.163%
FormLyophilized powder
CategoryGLP-1 and Incretin Research Peptides
Storage-20°C lyophilized · 2–8°C reconstituted
Published COA
Janoshik Report #204786
EU shipping
Ships from Romania to 32 countries
Research use only
Not for human consumption
Third-party lab report
Janoshik Analytical · Report #204786
PDF available — opens inline

Related products